Lung cancer prediction using machine learning on data from a symptom e-questionnaire for never smokers, formers smokers and current smokers

Author:

Nemlander Elinor,Rosenblad AndreasORCID,Abedi Eliya,Ekman Simon,Hasselström Jan,Eriksson Lars E.ORCID,Carlsson Axel C.ORCID

Abstract

Purpose The aim of the present study was to investigate the predictive ability for lung cancer of symptoms reported in an adaptive e-questionnaire, separately for never smokers, former smokers, and current smokers. Patients and methods Consecutive patients referred for suspected lung cancer were recruited between September 2014 and November 2015 from the lung clinic at the Karolinska University Hospital, Stockholm, Sweden. A total of 504 patients were later diagnosed with lung cancer (n = 310) or no cancer (n = 194). All participants answered an adaptive e-questionnaire with a maximum of 342 items, covering background variables and symptoms/sensations suspected to be associated with lung cancer. Stochastic gradient boosting, stratified on smoking status, was used to train and test a model for predicting the presence of lung cancer. Results Among never smokers, 17 predictors contributed to predicting lung cancer with 82% of the patients being correctly classified, compared with 26 predictors with an accuracy of 77% among current smokers and 36 predictors with an accuracy of 63% among former smokers. Age, sex, and education level were the most important predictors in all models. Conclusion Methods or tools to assess the likelihood of lung cancer based on smoking status and to prioritize investigative and treatment measures among all patients seeking care with diffuse symptoms are much needed. Our study presents risk assessment models for patients with different smoking status that may be developed into clinical risk assessment tools that can help clinicians in assessing a patient’s risk of having lung cancer.

Funder

Vetenskapsrådet

Vårdalstiftelsen

Strategic Research Area Health Care Science

Cancerföreningen i Stockholm

Sjöbergstiftelsen

AstraZeneca

Zero vision cancer

Einar Belven Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Predicting new cases of hypertension in Swedish primary care with a machine learning tool;Preventive Medicine Reports;2024-08

2. Web Based Real Time Bowel Cancer Stage Suggestion Using CNN;2024 2nd International Conference on Sustainable Computing and Smart Systems (ICSCSS);2024-07-10

3. Interpretable Predictive Modeling for Smoking and Drinking Behavior using SHAP and LIME;2024 International Conference on Current Trends in Advanced Computing (ICCTAC);2024-05-08

4. Lung Cancer Prediction Model and Its Progression;Advances in Clinical Medicine;2024

5. Correction: Lung cancer prediction using machine learning on data from a symptom e-questionnaire for never smokers, formers smokers and current smokers;PLOS ONE;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3